Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6509
    -0.0027 (-0.41%)
     
  • OIL

    82.58
    +1.23 (+1.51%)
     
  • GOLD

    2,236.80
    +24.10 (+1.09%)
     
  • Bitcoin AUD

    108,657.17
    -452.63 (-0.41%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6021
    -0.0010 (-0.17%)
     
  • AUD/NZD

    1.0895
    +0.0015 (+0.14%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,280.84
    +70.30 (+0.39%)
     
  • FTSE

    7,955.06
    +23.08 (+0.29%)
     
  • Dow Jones

    39,760.08
    +477.75 (+1.22%)
     
  • DAX

    18,490.38
    +13.29 (+0.07%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     

Chesapeake Energy Files Chapter 11

Ahead of the initial opening bell to start this holiday-shortened week — Friday, July 3rd, will be in observance of Independence Day — we have no new economic reports released. This will change dramatically as the week progresses, from Case-Shiller home prices and Consumer Prices tomorrow to ADP private-sector jobs and ISM Manufacturing and Services Wednesday to Initial Jobless Claims and a new Employment Situation report Friday.

Market futures are up this morning, following a sell-off day Friday on the increase in COVID-19 cases in the U.S. These numbers continue to get worse, as overall cases have hit a new 7-day average high in the U.S., with more than 40K cases reported Sunday and upwards of 50K expected sometime during this week. California, Texas and Florida have now reversed their reopening objectives as cases in those states begin to spiral out of control.

Drug maker Gilead GILD, which is creating the leading treatment for COVID-19 still being studied in phased testing, has announced its pricing for its treatment remdesivir when it comes to market: $520 per dose for private insurance, $390 for government and other developed countries. This news says nothing about when we might expect to obtain a dose of remdesivir, but these price points are roughly in-line with what analysts had been projecting.

This announcement comes a day after Health and Human Services (HHS) Secretary Alex Azar declared that President Trump has secured half a million courses of remdesivir. Now we can calculate how much this initial buy will cost.

ADVERTISEMENT

Chesapeake Energy (CHK) Files for Chapter 11

Finding difficulties in dealing with its now $10 billion in debt, fracking pioneer Chesapeake Energy CHK has announced it is filing for Chapter 11 bankruptcy protection. The Oklahoma City, OK-based company — whose founder and CEO Aubrey McClendon was instrumental in bringing the Seattle Supersonics NBA franchise to OK City, which founded the Thunder — was founded in 1989 and taken public in 1993.

Chesapeake was largely considered at the forefront of the at-the-time unconventional hydraulic fracturing (“fracking”) industry, which used immense pressure underground to unlock massive natural gas reserves. The company’s stock hits its apex in late June 2008, when its share price skyrocketed to $12,818 amid all-time high worldwide energy prices.

In the spring of 2016, one day after he had been indicted by a grand jury for rigging bids for oil and gas leases, McClendon died in a single-car crash in OK City. Since that time, Chesapeake has been on a slow but persistent drift downward. Its share price, now at $11.85, is down 97% over the past year. For more on this story, click here.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Chesapeake Energy Corporation (CHK) : Free Stock Analysis Report
 
Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research